Russia to sell 100 mln doses of COVID-19 vaccine to India - source
- Country:
- Russian Federation
Russia's sovereign wealth fund has agreed a deal to sell 100 million doses of its COVID-19 vaccine, Sputnik-V, to a major listed pharmaceutical company in India, a source close to the deal said on Wednesday.
Clinical trials of the Russian vaccine in India are expected to follow and to be held jointly with this firm, the source said. Both the trials and supply deal depend on domestic regulatory approval.
ALSO READ
-
Inside Russia’s SMR School, Where Nuclear Experience Shapes Future Energy Decisions
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
-
World Leaders Push for Fairer Pandemic Protection as COVID’s Heavy Toll Drives Action
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
Google News